He wasn't responsible for the patent expiration (a
Post# of 5066
The additional info required by the FDA is not something that he would be handling--that is information that will be submitted by Dr. Ichim and/or Dr. Min. And the additional info has nothing to do with whether or not the submission was done right the first time. It's additional info that is required because the FDA are covering all plausible issues. This could be a result of issues that have presented from other trials by other companies using similar approaches. Again, regardless of what so-called "docs" on the other board might say, this is business as usual for the FDA. This matter is no big deal in my opinion. The doctors know what they are doing.